Literature DB >> 20505193

Peripheral refraction in different ethnicities.

Pauline Kang1, Paul Gifford, Philomena McNamara, Jenny Wu, Stephanie Yeo, Bonney Vong, Helen Swarbrick.   

Abstract

PURPOSE: Peripheral refraction is commonly used to infer retinal shape. Because of the different prevalence of myopia in the white compared with East Asian populations, peripheral refraction along the horizontal meridian was compared in white and East Asian young adults with emmetropic, low myopic, and moderately myopic refractive errors.
METHODS: Thirty-five white and 37 East Asian subjects were recruited with central refraction between +1.00 DS and -5.50 DS and ≤ -1.50 DC. Central and peripheral noncycloplegic autorefraction was measured along the horizontal meridian at 5° intervals up to ± 35°, and corneal topography maps were also quantified.
RESULTS: There were no significant differences between whites and East Asians in peripheral refraction profiles in the emmetrope and low myope groups, which had peripheral myopic and emmetropic refraction, respectively. However, in the moderate myope group, there was a statistically significant difference between whites and East Asians in peripheral refraction, which was generally hyperopic. East Asian moderate myopes had more relative peripheral hyperopia than did whites of similar central refractive error. Corneal shape and power were comparable between white and East Asian subjects in the three refractive groups.
CONCLUSIONS: East Asian moderate myopes have a greater degree of relative peripheral hyperopia and hence a more prolate ocular shape than do white subjects of similar central refractive error. Differences in ocular shape may play a role in the greater propensity for East Asians to develop and progress in myopia compared with whites.

Entities:  

Mesh:

Year:  2010        PMID: 20505193     DOI: 10.1167/iovs.09-4747

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Relative peripheral defocus and myopic progression in children.

Authors:  David A Atchison
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

Review 2.  [Secondary diseases in high myopia].

Authors:  F Ziemssen; W Lagrèze; B Voykov
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

3.  Comparison of myopia progression between children wearing three types of orthokeratology lenses and children wearing single-vision spectacles.

Authors:  Yo Nakamura; Osamu Hieda; Isao Yokota; Satoshi Teramukai; Chie Sotozono; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2021-07-22       Impact factor: 2.447

4.  Variations in eyeball diameters of the healthy adults.

Authors:  Inessa Bekerman; Paul Gottlieb; Michael Vaiman
Journal:  J Ophthalmol       Date:  2014-11-05       Impact factor: 1.909

5.  Peripheral Refraction in Myopic Children with and without Atropine Usage.

Authors:  Han-Yin Sun; Wei-Yang Lu; Jhen-Yu You; Hui-Ying Kuo
Journal:  J Ophthalmol       Date:  2020-05-11       Impact factor: 1.909

Review 6.  Orthokeratology: clinical utility and patient perspectives.

Authors:  Jessie Charm
Journal:  Clin Optom (Auckl)       Date:  2017-02-07

Review 7.  Efficacy and Acceptability of Orthokeratology for Slowing Myopic Progression in Children: A Systematic Review and Meta-Analysis.

Authors:  Daizong Wen; Jinhai Huang; Hao Chen; Fangjun Bao; Giacomo Savini; Antonio Calossi; Haisi Chen; Xuexi Li; Qinmei Wang
Journal:  J Ophthalmol       Date:  2015-06-11       Impact factor: 1.909

8.  Patterns of posterior ocular complications in myopic eyes of Indian population.

Authors:  Rohit Dhakal; Abhilash Goud; Raja Narayanan; Pavan K Verkicharla
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

9.  Neutralizing Peripheral Refraction Eliminates Refractive Scotomata in Tilted Disc Syndrome.

Authors:  Jack Phu; Henrietta Wang; Sephora Miao; Lydia Zhou; Sieu K Khuu; Michael Kalloniatis
Journal:  Optom Vis Sci       Date:  2018-10       Impact factor: 1.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.